A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine - 07/08/11
Abstract |
Background |
Brunsting-Perry pemphigoid is a rare subepidermal blistering disease characterized by scarring blisters on the head and neck. However, the identity of the responsible autoantigens is still unresolved.
Methods |
We reported a patient with epidermolysis bullosa acquisita who had clinical features typical of Brunsting-Perry pemphigoid and investigated the involved type VII collagen epitopes. The patient was a 65-year-old Japanese woman with a 20-month history of recurrent subepidermal bullae on her head, face, and neck.
Results |
Immunoblot studies revealed that the serum of this patient reacted with type VII collagen, specifically with the noncollagenous domain 1 and the triple-helical domain. The patient responded completely to colchicine monotherapy.
Limitations |
This study was performed on only one case.
Conclusion |
This study suggests that Brunsting-Perry pemphigoid may be a clinical variant of epidermolysis bullosa acquisita.
Le texte complet de cet article est disponible en PDF.Key words : Brunsting-Perry pemphigoid, epidermolysis bullosa acquisita, type VII collagen
Plan
Supported by: a Grant-in-Aid for Scientific Research from and an Open Research Center Project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from the Ministry of Health, Labor, and Welfare (Research on Measures for Intractable Diseases 2008); the Uehara Memorial Foundation; and the Nakatomi Foundation. |
|
Conflicts of interest: None declared. |
Vol 61 - N° 4
P. 715-719 - octobre 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?